IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep

Market cap: $40.2B
P/E: 36.2×

Follow IDXX

Indexes indicate stock being part of an index,

Growth Flags show if company had growth for consecutive years

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
P/E ratio	47.42	52.60	42.96	52.65	73.40	75.34	50.00	53.85	38.39	51.33
P/S ratio	5.94	7.03	7.30	9.34	15.76	17.45	10.08	12.43	8.75	12.64
P/FCF ratio	38.49	46.70	58.79	75.78	78.94	88.83	88.38	59.64	47.28	56.88
P/Operating CF	104.73	114.35	119.12	144.69	194.85	267.19	195.77	182.09	130.12	152.94
P/B ratio	0.00	0.00	0.00	126.46	67.42	81.31	55.77	30.65	21.37	33.89
Price to Tangible BV	0.00	0.00	0.00	0.00	126.62	242.22	227.45	44.00	31.61	50.31
EV/Sales	6.06	7.10	7.52	9.72	15.95	17.67	10.28	12.49	8.83	12.71
EV/EBITDA	25.05	28.19	28.96	36.51	54.63	54.80	34.24	37.74	27.36	36.33
EV/Operating CF	31.73	37.47	41.58	50.96	66.64	75.19	63.74	50.46	37.06	46.27
EV/FCF	39.23	47.16	60.54	78.85	79.91	89.94	90.09	59.95	47.74	57.16
Quick Ratio	0.64	0.70	0.48	0.50	1.23	0.67	0.42	0.96	0.71	0.64
Current Ratio	0.90	0.97	0.85	0.94	1.82	1.25	0.89	1.57	1.31	1.23
Net Debt/EBITDA	1.89	1.59	1.53	1.42	0.66	0.68	0.65	0.20	0.26	0.18
Debt/Assets	78.66%	73.60%	65.07%	54.73%	39.59%	34.88%	28.01%	21.41%	18.75%	13.42%
Debt/Equity	(11.13)	(23.42)	(108.34)	5.64	1.44	1.23	1.26	0.47	0.39	0.28
Asset Turnover	1.18	1.21	1.36	1.43	1.31	1.36	1.30	1.22	1.19	1.30
Operating CF/Net income	1.53	1.42	1.06	1.07	1.11	1.01	0.80	1.07	1.05	1.12
Capex/Depreciation	(0.82)	(0.92)	(1.48)	(1.76)	(1.12)	(1.14)	(1.42)	(1.16)	(1.01)	(0.95)
Interest Coverage	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ROE	(231.05%)	(324.76%)	(1,195.50%)	507.40%	143.54%	112.62%	104.58%	80.74%	57.66%	66.20%
ROA	14.77%	16.22%	23.20%	25.39%	28.19%	31.48%	26.20%	28.14%	27.10%	31.89%
ROIC	31.09%	35.11%	35.41%	31.69%	37.51%	41.74%	44.39%	39.67%	36.64%	45.33%
Return on Tangible Assets	82.72%	75.94%	117.46%	87.62%	56.20%	95.52%	131.82%	67.83%	84.95%	104.65%
Average Days of Receivables	42.04	43.49	41.04	40.84	44.69	41.81	43.43	45.61	44.35	46.85
Research and Development Expense of Revenue	5.70%	5.54%	5.33%	5.53%	5.22%	5.01%	7.57%	5.22%	5.64%	5.84%
Selling, General and Administrative Expense of Revenue	29.52%	29.21%	28.57%	28.23%	27.17%	24.77%	25.26%	24.64%	26.45%	24.36%
Intangible Assets out of Total Assets	0.15	0.14	0.17	0.16	0.13	0.19	0.17	0.14	0.16	0.16
Share Based Compensation of Revenue	1.12%	1.19%	1.14%	1.63%	1.14%	1.17%	1.48%	1.63%	1.55%	1.39%
Graham Net Nets	(0.08)	(0.06)	(0.06)	(0.04)	(0.01)	(0.01)	(0.03)	(0.01)	(0.01)	(0.01)
Graham Number	0.00	0.00	0.00	15.18	33.71	39.91	36.47	63.95	68.47	76.94
Earnings Yield	2.11%	1.90%	2.33%	1.90%	1.36%	1.33%	2.00%	1.86%	2.60%	1.95%
Free Cash Flow Yield	2.60%	2.14%	1.70%	1.32%	1.27%	1.13%	1.13%	1.68%	2.11%	1.76%
Revenue per Share	19.79	22.43	25.48	27.95	31.72	37.74	40.27	44.07	47.26	53.51
Operating CF per Share	3.78	4.25	4.61	5.33	7.59	8.87	6.49	10.91	11.27	14.69
Capex per Share	(0.72)	(0.87)	(1.42)	(1.80)	(1.26)	(1.40)	(1.90)	(1.61)	(1.59)	(1.72)
Free Cash Flow per Share	3.06	3.38	3.19	3.53	6.33	7.46	4.59	9.30	9.68	12.98
Cash per Share	4.37	5.38	1.43	1.05	4.50	1.70	1.35	5.46	3.50	2.24
Shareholders Equity per Share	(1.21)	(0.61)	(0.11)	2.07	7.41	8.10	7.28	17.87	19.34	19.96
Interest Debt per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Book value per Share	(1.21)	(0.61)	(0.11)	2.07	7.41	8.10	7.28	17.87	19.34	19.96
Free Cash Flow	274.16	296.57	277.15	303.93	540.44	636.00	384.15	772.88	798.08	1,043.58
Working Capital	(88.98)	(32.58)	(116.27)	(45.70)	479.98	192.08	(134.33)	543.71	331.98	265.01
Capital Expenditures	(64.79)	(76.70)	(122.94)	(155.22)	(107.63)	(119.55)	(158.84)	(133.63)	(130.92)	(138.23)
Net Current Asset Value	(793.33)	(795.27)	(892.41)	(975.01)	(599.03)	(791.56)	(1,036.55)	(280.14)	(298.23)	(331.55)
EV/EBIT	30.71	33.86	33.86	42.33	62.18	60.95	38.51	41.69	30.51	40.21
Capex to Sales	0.04	0.04	0.06	0.06	0.04	0.04	0.05	0.04	0.03	0.03
Net Profit Margin	12.51%	13.36%	17.04%	17.77%	21.49%	23.17%	20.17%	23.08%	22.78%	24.62%
Price to Operating Income	30.13	33.53	32.89	40.68	61.42	60.19	37.78	41.47	30.22	40.01
Other line items
Depreciation/Fixed assets	0.22	0.22	0.19	0.16	0.17	0.18	0.17	0.16	0.18	0.19
Cash ROIC	(1.24%)	(0.35%)	(3.34%)	(5.88%)	4.83%	9.97%	(7.14%)	7.75%	8.63%	19.43%
Accounts Receivable Turnover	9.04	8.97	9.16	9.29	9.01	9.19	8.76	8.53	8.37	8.39
Accounts Payable Turnover	14.20	13.72	14.24	14.70	15.48	13.91	12.04	13.32	13.51	14.64
Inventory Turnover	4.61	5.41	5.76	5.65	5.61	5.54	4.28	3.93	3.98	4.33
Average Days of Payables	27.40	28.04	26.12	25.30	23.96	31.97	29.52	27.45	27.45	24.51
Days of Inventory on Hand	72.10	68.81	65.10	68.35	67.46	74.06	98.50	94.36	91.79	83.86
Average Receivables	196.41	219.55	241.73	259.08	300.37	349.89	384.48	429.03	465.51	512.98
Average Payables	56.35	63.51	68.25	70.85	73.37	95.35	113.18	110.43	112.43	112.31
Average Inventory	173.43	161.18	168.81	184.16	202.45	239.45	318.43	374.05	381.08	379.82
Average Assets	1,502.85	1,622.06	1,625.38	1,684.91	2,063.52	2,365.88	2,591.98	3,003.35	3,276.68	3,322.10
Average Common Equity	(96.10)	(81.03)	(31.54)	84.30	405.31	661.39	649.36	1,046.63	1,539.92	1,600.35

Show all line items

Columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

IDEXX Laboratories, Inc. IDXX